Atlas Trials

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

Clinical trial NCT04705597 · TERMINATED

Trial details

NCT number
NCT04705597
Sponsor
BioAge Labs, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2021-03-18
Primary completion
2022-04-20
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.